...
首页> 外文期刊>Journal of Cancer Therapy >The Percentage of Stained Cells is a More Reliable Parameter in Immunohistochemical Analysis than Scoring the Intensity of Staining: Expression of 9 Molecular Markers in Progression and Liver Metastases of Colorectal Cancer
【24h】

The Percentage of Stained Cells is a More Reliable Parameter in Immunohistochemical Analysis than Scoring the Intensity of Staining: Expression of 9 Molecular Markers in Progression and Liver Metastases of Colorectal Cancer

机译:染色细胞的百分比是免疫组织化学分析中的一种更可靠的参数,而不是评分染色强度:9分子标志物在结直肠癌的肝脏转移中的表达

获取原文

摘要

Aims: Research for reliable molecular markers that provide prognostic and predictive information in colorectal cancer (CRC) is based on solid evidence that the staging system on its own cannot definitively predict the tumor behavior and guide clinical management of the disease. Methods and results: In this study we examined the immunohistochemical expression of 9 markers, namely membrane-bound mucin 1 (MUC1), paxillin (PAX), Focal Adhesion Kinase (FAK), G-protein coupled receptor 56 (GPR56), ORAI3 and well known markers of colon carcinoma microsatellite instability (MSI): MSH2, MSH6, MLH1 and PMS2 with respect to the percentage of stained cells and intensity score in colon carcinoma cells, both in the primary tumor and liver metastasis. We have related all of the mentioned markers with clinicopathological data, including the age of patients, grading of the primary tumor and TNM system. Western blotting assay was performed to identify the expression. Our present study showed that the evaluation of different markers with respect to intensity of staining and percentage of stained cancer cells may be considered as a prognostic marker for tumor progression and later for liver metastasis. This has been found for the percentage of stained cells particularly. Conclusions: Our results implicate that the counting percentage of stained colon cancer cells provides a more adequate method of immunohistochemical analysis than evaluation of the intensity of staining.
机译:目的:在结直肠癌(CRC)中提供预后和预测信息的可靠分子标记的研究是基于固体证据,即其自身不能明确地预测该疾病的肿瘤行为和指导临床管理。方法和结果:在该研究中,我们检查了9个标记的免疫组织化学表达,即膜结合的粘蛋白1(MUC1),百素(PAX),局灶性粘附激酶(FAK),G-蛋白偶联受体56(GPR56),orai3和众所周知的结肠癌微卫星不稳定性(MSI):MSH2,MSH6,MLH1和PMS2相对于染色细胞的百分比和结肠癌细胞中的强度评分,在原发性肿瘤和肝转移中。我们已向临床病理数据相关所有提到的标记,包括患者年龄,原发性肿瘤和TNM系统的分级。进行蛋白质印迹测定以鉴定表达。我们目前的研究表明,对染色癌细胞的强度和染色癌细胞百分比的评价可以被认为是肿瘤进展的预后标志物,后来用于肝转移。这已被发现尤其是染色细胞的百分比。结论:我们的结果涉及染色的结肠癌细胞的计数百分比提供了比染色强度的评估更适当的免疫组化分析方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号